MMP9 and neoplasm: Thus, the combination of VEGF inhibitors following TACE could, theoretically, regulate the expressions of cancer-promoting factors, e.g. VEGF and MMP-9, inhibit angiogenesis of tumors, and eventually reduce the possibility of tumor recurrence and metastasis.